ENUMERIX
LIVE

Serial Number

98536369

Owner

Enumerix, Inc.

Attorney

Brian J. Focarino

Filing Date

May 6, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ENUMERIX Trademark

Serial Number: 98536369

ENUMERIX is a trademark filed by Enumerix, Inc. on May 6, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Enumerix, Inc. (11 trademarks)

4030 Fabian Way
Palo Alto, CA 94303

Entity Type: 03

Trademark Details

Filing Date

May 6, 2024

Registration Date

Not Registered

Published for Opposition

June 24, 2025

Goods & Services

Laboratory reagents for research purposes; enzyme and enzyme preparations for research purposes; polymerase chain reaction (PCR) reagents for research purposes; polymerase chain reaction (PCR) enzymes for research purposes; reverse transcriptions enzymes for research purposes; reagent polymerase chain reaction (PCR) master mixes, namely, pre-mixed reactants and reagents for research purposes; all the following sold individually or together as a kit, for quantitative polymerase chain reaction and quantitative reverse transcription polymerase chain reaction; scientific research kits comprising nucleotides for scientific and research use, diagnostic reagents, enzymes, agents in the nature of biochemical reagents used for non-medical purpose, assays for research purposes, buffer solutions for use in analytical chemistry and molecular biology, chemical preparations for scientific purposes used for nucleic acid sequencing, genotyping, genetics, agriculture, and metagenomics, and biological preparations for use in science used for nucleic acid sequencing, genotyping, genetics, agriculture, and metagenomics, all for use in scientific research other than for medical or veterinary use; chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations, except for medical and veterinary medical purposes; reagents and solvents for scientific and research use for the preparation of samples, the modification and manipulation of samples and for performing marking, separation, isolation, purification, reproduction and analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances; diagnostic components for molecular biology diagnostic scientific testing, namely, diagnostic reagents for scientific use

Diagnostic components for molecular biology diagnostic testing, namely, diagnostic reagents for medicinal use

Polymerase chain reaction (PCR) testing for scientific research purposes; scientific consulting and contract research services in the field of polymerase chain reaction (PCR) testing

Imaging apparatus and instruments, namely, non-medical imaging devices for the study of polymerase chain reaction (PCR) testing for scientific research purposes; downloadable software for facilitating and performing polymerase chain reaction (PCR) testing; laboratory equipment, namely, non-medical imaging devices using electronic detection for molecular diagnostics and molecular diagnostics analyzers; laboratory equipment, namely, non-medical imaging devices for use in the quantification of nucleic acids for use in research, translational, and clinical analysis; laboratory equipment, namely, non-medical imaging devices for use in the quality control of gene editing; laboratory equipment, namely, non-medical imaging devices for use in the detection, quantification, and monitoring of nucleic acids and molecular diagnostics.

Filing History

SOU EXTENSION 1 GRANTED
Feb 3, 2026 EX1G
SOU EXTENSION 1 FILED
Feb 3, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 3, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 19, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 24, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 24, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 18, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 23, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 21, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 20, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 20, 2025 XELR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 19, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 19, 2025 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 22, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 22, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 22, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 20, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 3, 2024 NWOS
NEW APPLICATION ENTERED
May 6, 2024 NWAP